Skip to main
OMDA

OMDA Stock Forecast & Price Target

OMDA Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 38%
Buy 46%
Hold 15%
Sell 0%
Strong Sell 0%

Bulls say

Omada Health is poised for success with its proven track record of providing effective virtual care for chronic conditions, strong partnerships, and plans for expansion into new markets. With a goal of 20% annual revenue growth, the company's recent acquisition and new leadership signal potential for further success and value for investors. With its focus on reducing healthcare costs and improving health outcomes, Omada's financials and key data metrics are likely to reflect continued growth and success in the future.

Bears say

Omada Health is facing a number of challenges that could negatively impact its future prospects and growth potential. These challenges include a heavy reliance on a few major partners for revenue and membership growth, potential risks and limitations of virtual healthcare platforms, operational and technology issues, increasing costs and potential profitability concerns, and competition in a highly crowded virtual healthcare market. Additionally, while Omada Health's platform has shown promising results, it may not be the best or most comprehensive option for individuals with certain conditions, requiring them to still rely on traditional healthcare methods. Overall, these factors contribute to a negative outlook for Omada Health's stock.

OMDA has been analyzed by 13 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 46% recommend Buy, 15% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omada Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omada Health Inc (OMDA) Forecast

Analysts have given OMDA a Buy based on their latest research and market trends.

According to 13 analysts, OMDA has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $26.85, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $26.85, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omada Health Inc (OMDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.